首页> 美国卫生研究院文献>BioMed Research International >Effects of DL-Homocysteine Thiolactone on Cardiac Contractility, Coronary Flow, and Oxidative Stress Markers in the Isolated Rat Heart: The Role of Different Gasotransmitters
【2h】

Effects of DL-Homocysteine Thiolactone on Cardiac Contractility, Coronary Flow, and Oxidative Stress Markers in the Isolated Rat Heart: The Role of Different Gasotransmitters

机译:DL-高半胱氨酸硫代内酯对离体大鼠心脏的收缩力,冠状动脉血流和氧化应激标志物的影响:不同气体递质的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Considering the adverse effects of DL-homocysteine thiolactone hydrochloride (DL-Hcy TLHC) on vascular function and the possible role of oxidative stress in these mechanisms, the aim of this study was to assess the influence of DL-Hcy TLHC alone and in combination with specific inhibitors of important gasotransmitters, such as L-NAME, DL-PAG, and PPR IX, on cardiac contractility, coronary flow, and oxidative stress markers in an isolated rat heart. The hearts were retrogradely perfused according to the Langendorff technique at a 70 cm H2O and administered 10 μM DL-Hcy TLHC alone or in combination with 30 μM L-NAME, 10 μM DL-PAG, or 10 μM PPR IX. The following parameters were measured: dp/dt max, dp/dt min, SLVP, DLVP, MBP, HR, and CF. Oxidative stress markers were measured spectrophotometrically in coronary effluent through TBARS, NO2, O2 , and H2O2 concentrations. The administration of DL-Hcy TLHC alone decreased dp/dt max, SLVP, and CF but did not change any oxidative stress parameters. DL-Hcy TLHC with L-NAME decreased CF, O2 , H2O2, and TBARS. The administration of DL-Hcy TLHC with DL-PAG significantly increased dp/dt max but decreased DLVP, CF, and TBARS. Administration of DL-Hcy TLHC with PPR IX caused a decrease in dp/dt max, SLVP, HR, CF, and TBARS.
机译:考虑到DL-高半胱氨酸硫代内酯盐酸盐(DL-Hcy TLHC)对血管功能的不利影响以及氧化应激在这些机制中的可能作用,本研究的目的是评估DL-Hcy TLHC单独或与DL-Hcy TLHC联合使用时的影响。重要的气体递质(例如L-NAME,DL-PAG和PPR IX)对离体大鼠心脏中的心脏收缩性,冠状动脉血流和氧化应激标志物的特异性抑制剂。根据Langendorff技术在70?cm H2O处逆行灌注心脏,并单独给予10?μMDL-Hcy TLHC或与30?μML-NAME,10?μMDL-PAG或10?μMPPR IX组合使用。测量以下参数:dp / dt max,dp / dt min,SLVP,DLVP,MBP,HR和CF。通过TBARS,NO2,O2 -和H2O2浓度分光光度法测定了冠状流出物中的氧化应激标志物。单独施用DL-Hcy TLHC可降低dp / dt max,SLVP和CF,但不会改变任何氧化应激参数。具有L-NAME的DL-Hcy TLHC降低了CF,O2 -,H2O2和TBARS。将DL-Hcy TLHC与DL-PAG一起使用可显着提高dp / dt max,但可降低DLVP,CF和TBARS。 DL-Hcy TLHC与PPR IX的给药导致dp / dt max,SLVP,HR,CF和TBARS降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号